loading
Precedente Chiudi:
$24.77
Aprire:
$25
Volume 24 ore:
43,405
Relative Volume:
0.19
Capitalizzazione di mercato:
$988.61M
Reddito:
$982.01M
Utile/perdita netta:
$14.80M
Rapporto P/E:
68.24
EPS:
0.37
Flusso di cassa netto:
$37.02M
1 W Prestazione:
+4.92%
1M Prestazione:
+8.18%
6M Prestazione:
+16.17%
1 anno Prestazione:
+43.33%
Intervallo 1D:
Value
$24.72
$25.36
Intervallo di 1 settimana:
Value
$23.57
$25.36
Portata 52W:
Value
$16.16
$26.55

Phibro Animal Health Corp Stock (PAHC) Company Profile

Name
Nome
Phibro Animal Health Corp
Name
Telefono
201-329-7300
Name
Indirizzo
GLENPOINTE CENTRE EAST, 3RD FLOOR, TEANECK, NJ
Name
Dipendente
1,940
Name
Cinguettio
@phibroeurope
Name
Prossima data di guadagno
2024-12-06
Name
Ultimi documenti SEC
Name
PAHC's Discussions on Twitter

Confronta PAHC con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Drug Manufacturers - Specialty & Generic icon
PAHC
Phibro Animal Health Corp
25.25 988.61M 982.01M 14.80M 37.02M 0.37
Drug Manufacturers - Specialty & Generic icon
RGC
Regencell Bioscience Holdings Ltd
24.80 303.95B 0 -5.87M -767.30K -0.45
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
157.12 74.39B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
10.44 48.97B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.94 47.39B 30.08B 710.16M 4.45B 0.2182
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
17.05 20.17B 16.54B -1.64B 749.00M -1.45

Phibro Animal Health Corp Stock (PAHC) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-06-16 Aggiornamento BNP Paribas Exane Underperform → Neutral
2024-09-10 Iniziato JP Morgan Neutral
2023-12-07 Iniziato Exane BNP Paribas Underperform
2022-12-21 Iniziato ROTH Capital Buy
2022-07-25 Downgrade Barclays Equal Weight → Underweight
2022-01-10 Aggiornamento Barclays Underweight → Equal Weight
2021-11-18 Iniziato Morgan Stanley Equal-Weight
2021-08-05 Ripresa Credit Suisse Neutral
2021-07-07 Downgrade Barclays Equal Weight → Underweight
2020-08-06 Downgrade Morgan Stanley Equal-Weight → Underweight
2020-02-06 Downgrade Gabelli & Co Buy → Hold
2020-01-28 Aggiornamento Barclays Underweight → Equal Weight
2019-09-05 Aggiornamento Morgan Stanley Underweight → Equal-Weight
2019-08-29 Reiterato BofA/Merrill Underperform
2019-06-11 Iniziato Barclays Underweight
2019-05-23 Iniziato Guggenheim Neutral
2019-05-09 Aggiornamento Gabelli & Co Hold → Buy
2017-08-23 Ripresa BofA/Merrill Underperform
2017-06-02 Downgrade Credit Suisse Outperform → Neutral
2016-12-15 Iniziato Piper Jaffray Overweight
2016-11-11 Downgrade Macquarie Neutral → Underperform
2016-11-10 Downgrade Gabelli & Co Buy → Hold
2016-04-11 Reiterato Guggenheim Buy
2016-02-04 Iniziato Credit Suisse Outperform
2016-01-15 Downgrade Barclays Overweight → Underweight
2015-09-30 Iniziato Gabelli & Co Buy
2015-04-24 Reiterato Barclays Overweight
2015-04-21 Downgrade Morgan Stanley Equal-Weight → Underweight
2014-05-06 Iniziato Barclays Overweight
Mostra tutto

Phibro Animal Health Corp Borsa (PAHC) Ultime notizie

pulisher
Jun 18, 2025

Reasons to Add PAHC Stock to Your Portfolio Right Now - Yahoo Finance

Jun 18, 2025
pulisher
Jun 18, 2025

GAMMA Investing LLC Has $784,000 Stock Position in Phibro Animal Health Corporation (NASDAQ:PAHC) - Defense World

Jun 18, 2025
pulisher
Jun 17, 2025

Phibro Animal Health (NASDAQ:PAHC) Upgraded to “Neutral” at BNP Paribas Exane - Defense World

Jun 17, 2025
pulisher
Jun 16, 2025

Zacks.com featured highlights include Popular, Affiliated Managers, Astronics and Phibro Animal Health - The Globe and Mail

Jun 16, 2025
pulisher
Jun 16, 2025

Phibro Animal Health upgraded to Neutral from Underperform at BNP Paribas Exane - TipRanks

Jun 16, 2025
pulisher
Jun 16, 2025

Phibro Animal Health (PAHC) Rating Upgraded by Analyst | PAHC Stock News - GuruFocus

Jun 16, 2025
pulisher
Jun 13, 2025

Are Investors Undervaluing Phibro Animal Health (PAHC) Right Now? - Yahoo Finance

Jun 13, 2025
pulisher
Jun 12, 2025

Bank of America Corp DE Cuts Stake in Phibro Animal Health Co. (NASDAQ:PAHC) - Defense World

Jun 12, 2025
pulisher
Jun 09, 2025

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Acquires 16,917 Shares of Phibro Animal Health Co. (NASDAQ:PAHC) - Defense World

Jun 09, 2025
pulisher
Jun 06, 2025

Phibro (PAHC) Up 7.4% Since Last Earnings Report: Can It Continue? - Yahoo Finance

Jun 06, 2025
pulisher
Jun 06, 2025

Why Phibro Animal Health (PAHC) is a Top Momentum Stock for the Long-Term - Yahoo Finance

Jun 06, 2025
pulisher
Jun 04, 2025

Zacks.com featured highlights Urban Outfitters, Phibro Animal Health and Strattec Security - Yahoo Finance

Jun 04, 2025
pulisher
Jun 03, 2025

3 Stocks Showing Positive Momentum Despite Trade Tensions - Yahoo Finance

Jun 03, 2025
pulisher
Jun 02, 2025

Cetera Investment Advisers Takes $204,000 Position in Phibro Animal Health Co. (NASDAQ:PAHC) - Defense World

Jun 02, 2025
pulisher
May 31, 2025

Jane Street Group LLC Trims Stock Position in Phibro Animal Health Co. (NASDAQ:PAHC) - Defense World

May 31, 2025
pulisher
May 31, 2025

Deutsche Bank AG Boosts Stock Holdings in Phibro Animal Health Co. (NASDAQ:PAHC) - Defense World

May 31, 2025
pulisher
May 31, 2025

Ameriprise Financial Inc. Purchases 21,576 Shares of Phibro Animal Health Co. (NASDAQ:PAHC) - Defense World

May 31, 2025
pulisher
May 30, 2025

Millennium Management LLC Has $4.36 Million Position in Phibro Animal Health Co. (NASDAQ:PAHC) - Defense World

May 30, 2025
pulisher
May 29, 2025

Phibro at Stifel Jaws & Paws Conference: Strategic Growth and Challenges - Investing.com India

May 29, 2025
pulisher
May 29, 2025

Here's Why Phibro Animal Health (PAHC) is a Strong Value Stock - Yahoo Finance

May 29, 2025
pulisher
May 28, 2025

Is Phibro Animal Health (PAHC) Stock Undervalued Right Now? - Yahoo Finance

May 28, 2025
pulisher
May 27, 2025

Phibro Animal Health Co. (NASDAQ:PAHC) Shares Purchased by Lazard Asset Management LLC - Defense World

May 27, 2025
pulisher
May 27, 2025

Phibro Animal Health Co. (NASDAQ:PAHC) Shares Sold by BNP Paribas Financial Markets - Defense World

May 27, 2025
pulisher
May 27, 2025

D. E. Shaw & Co. Inc. Trims Stock Holdings in Phibro Animal Health Co. (NASDAQ:PAHC) - Defense World

May 27, 2025
pulisher
May 23, 2025

Best Value Stocks to Buy for May 23rd - Yahoo Finance

May 23, 2025
pulisher
May 22, 2025

Phibro Animal Health COO and Strategy Chief Set to Reveal Business Updates at Stifel Conference - Stock Titan

May 22, 2025
pulisher
May 21, 2025

What Makes Phibro Animal Health (PAHC) a Strong Momentum Stock: Buy Now? - Yahoo Finance

May 21, 2025
pulisher
May 21, 2025

Phibro Animal Health Co. (NASDAQ:PAHC) Shares Bought by Northern Trust Corp - Defense World

May 21, 2025
pulisher
May 15, 2025

Solid Earnings Reflect Phibro Animal Health's (NASDAQ:PAHC) Strength As A Business - Yahoo Finance

May 15, 2025
pulisher
May 13, 2025

Why Phibro Animal Health (PAHC) is a Top Value Stock for the Long-Term - Yahoo Finance

May 13, 2025
pulisher
May 13, 2025

International Markets and Phibro (PAHC): A Deep Dive for Investors - Yahoo Finance

May 13, 2025
pulisher
May 13, 2025

Phibro Animal Health Corporation (NASDAQ:PAHC) Q3 2025 Earnings Call Transcript - Insider Monkey

May 13, 2025
pulisher
May 12, 2025

Phibro Animal Health Corp’s Earnings Call Highlights Robust Growth - TipRanks

May 12, 2025
pulisher
May 12, 2025

3 Reasons Growth Investors Will Love Phibro (PAHC) - Yahoo Finance

May 12, 2025
pulisher
May 12, 2025

Should Value Investors Buy Phibro Animal Health (PAHC) Stock? - Yahoo Finance

May 12, 2025
pulisher
May 12, 2025

Phibro Animal Health (NASDAQ:PAHC) Upgraded at StockNews.com - Defense World

May 12, 2025
pulisher
May 11, 2025

Phibro Animal Health (NASDAQ:PAHC) Shares Gap Down – Time to Sell? - Defense World

May 11, 2025
pulisher
May 10, 2025

Phibro Animal Health's (NASDAQ:PAHC) Dividend Will Be $0.12 - Yahoo Finance

May 10, 2025
pulisher
May 09, 2025

Phibro Animal Health (PAHC) Target Price Raised to $21 by Morgan Stanley | PAHC Stock News - GuruFocus

May 09, 2025
pulisher
May 09, 2025

Phibro Animal Health Co. (NASDAQ:PAHC) Stake Trimmed by Dimensional Fund Advisors LP - Defense World

May 09, 2025
pulisher
May 09, 2025

Phibro Animal Health (NASDAQ:PAHC) Trading 12.6% Higher Following Better-Than-Expected Earnings - Defense World

May 09, 2025
pulisher
May 09, 2025

Phibro Animal Health Corp (PAHC) Q3 2025 Earnings Call Highlights: Robust Sales Growth and ... - Yahoo Finance

May 09, 2025
pulisher
May 09, 2025

Phibro Animal Health Corp. Reaches Analyst Target Price - Nasdaq

May 09, 2025
pulisher
May 09, 2025

Phibro Animal Health Corp (PAHC) Q3 2025 Earnings Call Highlights: Robust Sales Growth and Strategic Investments Propel Performance - GuruFocus

May 09, 2025
pulisher
May 08, 2025

Earnings call transcript: Phibro Animal Health beats Q3 2025 expectations - Investing.com

May 08, 2025
pulisher
May 08, 2025

Phibro Q3 2025 slides: Animal Health segment drives 32% revenue surge By Investing.com - Investing.com South Africa

May 08, 2025
pulisher
May 08, 2025

Phibro Q3 2025 slides: Animal Health segment drives 32% revenue surge - Investing.com Canada

May 08, 2025
pulisher
May 08, 2025

Morgan Stanley Adjusts Price Target on Phibro Animal Health to $21 From $20, Maintains Equalweight Rating - marketscreener.com

May 08, 2025
pulisher
May 08, 2025

Morgan Stanley Adjusts Phibro Animal Health (PAHC) Price Target Following Q3 Performance | PAHC Stock News - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Phibro Q3 Earnings Top Estimates, Stock Up, 2025 EPS Outlook Raised - Yahoo Finance

May 08, 2025
pulisher
May 08, 2025

Envestnet Asset Management Inc. Buys New Stake in Phibro Animal Health Co. (NASDAQ:PAHC) - Defense World

May 08, 2025

Phibro Animal Health Corp Azioni (PAHC) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Phibro Animal Health Corp Azioni (PAHC) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
CORCORAN E THOMAS
Director
Feb 24 '25
Buy
22.10
5,000
110,500
30,000
$13.57
price up icon 0.13%
$8.915
price down icon 0.45%
$127.14
price down icon 0.69%
$289.47
price down icon 0.26%
drug_manufacturers_specialty_generic RDY
$15.54
price down icon 0.32%
$17.05
price down icon 0.18%
Capitalizzazione:     |  Volume (24 ore):